New York, USA, March 05, 2025 (GLOBE NEWSWIRE) -- Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight The growing incidence of genetic disorders and ...

The Burkitt lymphoma market is expected to experience significant growth across the seven major markets (7MM), which include the United States, EU4 (Germany, France, Italy, and Sp ...

This in-depth analysis shows that the Global Stationary Fuel Cell Market, valued at 613.83 MW Units 2023, is set for substantial growth and is projected to reach 3117.69 MW by 2032. This ...

report_id=bw8534 Global Cell Line Development Market is valued approximately at USD 3,124.4 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.1% over the forecast ...

The Global Mesenchymal Stem Cells (MSCs) Market, valued at approximately $ 3,257.5 million in 2023, is poised for robust growth, with projections suggesting a compound annual growth rate (CAGR) of ...

and strategic industry initiatives are expected to drive substantial growth in North America's cell and gene therapy manufacturing market from 2025 to 2032. To know more about why North America is ...